Novartis Consumer Health has dealt a blow to Lyons Waddell by
handing PR for its antiseptic cream Savlon and nicotine replacement
brand Nicotinell to other agencies.
Red Rooster PR started work this week on a pounds 100,000 consumer and
trade PR account for Nicotinell, while Bloomsbury Communications is now
handling consumer and trade PR for Savlon. Bloomsbury already handles
Novartis’ children’s cough medicine brand, Tixy Lix.
The brief is to make Savlon, which includes cream and liquid antiseptic
products, synonymous with first aid, targeting mothers with children
between five and ten-years-old.
Lyons Waddell, which was not involved in either pitch, no longer handles
any PR for Novartis. The agency declined to comment.
Red Rooster’s hiring comes as Novartis looks to give Nicotinell’s
marketing a more positive edge, changing its strapline from ’It needn’t
be hell with Nicotinell’ to ’Feel free’ two weeks ago.
Red Rooster has been briefed to promote Nicotinell gum and patch
products and Nicotinell’s recently launched web site, which provides
programmes for smokers to help them quit.
It will also promote the idea of quitting in the summer, believed to be
the least likely time for people to give up.